Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

X-Inactivation01:58

X-Inactivation

42.7K
The human X chromosome contains over ten times the number of genes as in the Y chromosome. Since males have only one X chromosome, and females have two, one might expect females to produce twice as many of the proteins, with undesirable results.
42.7K
Vaccinations01:51

Vaccinations

51.9K
Overview
51.9K
Activation and Inactivation of G Proteins01:22

Activation and Inactivation of G Proteins

11.7K
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high...
11.7K
Cancer Vaccines01:30

Cancer Vaccines

1.1K
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
1.1K
Lewis Acids and Bases02:33

Lewis Acids and Bases

48.5K
In 1923, G. N. Lewis proposed a generalized definition of acid-base behavior in which acids and bases are identified by their ability to accept or to donate a pair of electrons and form a coordinate covalent bond.
A coordinate covalent bond (or dative bond) occurs when one of the atoms in the bond provides both bonding electrons. For example, a coordinate covalent bond occurs when a water molecule combines with a hydrogen ion to form a hydronium ion. A coordinate covalent bond also results when...
48.5K
Weak Base Solutions03:21

Weak Base Solutions

25.5K
Some compounds produce hydroxide ions when dissolved by chemically reacting with water molecules. In all cases, these compounds react only partially and so are classified as weak bases. These types of compounds are also abundant in nature and important commodities in various technologies. For example, global production of the weak base ammonia is typically well over 100 metric tons annually, being widely used as an agricultural fertilizer, a raw material for chemical synthesis of other...
25.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Influenza virus infection drives upregulation of CD84 across a broad range of immune cells.

Clinical & translational immunology·2026
Same author

Lipid nanoparticle-encapsulated microRNA-192: An anti-inflammatory adjuvant that enhances vaccine efficacy in aged mice.

Molecular therapy. Nucleic acids·2025
Same author

High expression of interleukin-18 receptor alpha correlates with severe respiratory viral disease and defines T cells with reduced cytotoxic signatures.

Nature communications·2025
Same author

A refined low-dose murine model of <i>Mycobacterium ulcerans</i> infection to assess integrated immune networks in Buruli ulcer pathogenesis.

mBio·2025
Same author

A Case of Infection with Leptospires from Three Different Serovars During a Flood in the Philippines.

The American journal of tropical medicine and hygiene·2025
Same author

Optimization of the preparation method of inactivated intact virus particle vaccine for COVID-19.

Vaccine·2025

Related Experiment Video

Updated: Feb 15, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.5K

Opinion: Making Inactivated and Subunit-Based Vaccines Work.

Brendon Y Chua1,2,3, Toshiki Sekiya2,3, David C Jackson1,2,3

  • 11 Department of Microbiology and Immunology, The Peter Doherty Institute for Infection and Immunity, The University of Melbourne , Melbourne, Australia .

Viral Immunology
|January 26, 2018
PubMed
Summary

This review explores rational vaccine design, focusing on inactivated influenza virus vaccines. It highlights improving vaccine efficacy using adjuvants and Toll-like receptor-2 signaling for better immune responses.

Keywords:
Toll-like receptor-2inactivatedsubunit

More Related Videos

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.7K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Related Experiment Videos

Last Updated: Feb 15, 2026

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
12:09

Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection

Published on: May 2, 2011

43.5K
Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines
05:39

Immunization of Adult Zebrafish for the Preclinical Screening of DNA-based Vaccines

Published on: October 30, 2018

12.7K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.8K

Area of Science:

  • Vaccinology and Immunology
  • Infectious Disease Research

Background:

  • Traditional vaccines relied on empirical methods without understanding immunity mechanisms.
  • Past vaccine development often involved inactivating or attenuating pathogens without full knowledge of protective immunity.

Purpose of the Study:

  • To discuss ideal attributes and criteria for vaccine development.
  • To review existing vaccine platforms, with a focus on inactivated vaccines.
  • To explore strategies for enhancing vaccine efficacy, particularly for influenza virus vaccines.

Main Methods:

  • Review of scientific literature on vaccine development and immunological mechanisms.
  • Focus on inactivated whole-organism and subunit vaccine platforms.
  • Discussion of adjuvants and Toll-like receptor-2 (TLR2) signaling pathways.

Main Results:

  • Advances in technology and immunology enable rational vaccine design.
  • Inactivated whole-organism and subunit vaccines have seen accelerated development.
  • Adjuvants and TLR2 signaling show potential for improving vaccine efficacy.

Conclusions:

  • Rational vaccine design offers safer and more effective strategies.
  • Inactivated influenza vaccines can be enhanced through specific immune-modulating approaches.
  • Understanding immune induction mechanisms is key to future vaccine innovation.